<div id="readability-page-1"><p><span>UnitedHealth Group (NYSE:UNH - Get Free Report)</span> had its price target dropped by stock analysts at Piper Sandler  from $353.00 to $317.00 in a report issued on Wednesday,Benzinga reports. The firm currently has an &#34;overweight&#34; rating on the healthcare conglomerate's stock. Piper Sandler's target price would suggest a potential upside of 21.52% from the stock's current price.</p><div><p><span></span><span>Get <strong>UnitedHealth Group</strong> alerts:</span></p></div><ul><li>Can HCA Healthcare Revive the Market’s Weakest Sector?</li></ul><p>Several other brokerages have also recently issued reports on UNH. UBS Group  reiterated a &#34;buy&#34; rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Robert W. Baird lowered UnitedHealth Group from an &#34;outperform&#34; rating to a &#34;neutral&#34; rating and set a $312.00 price target on the stock. in a research report on Wednesday, June 11th. KeyCorp reduced their price target on UnitedHealth Group from $400.00 to $350.00 and set an &#34;overweight&#34; rating for the company in a report on Wednesday. Mizuho lowered their price target on UnitedHealth Group from $515.00 to $350.00 and set an &#34;outperform&#34; rating on the stock in a report on Friday, May 16th. Finally, Argus lowered UnitedHealth Group from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report on Monday, April 21st. One analyst  has rated the stock with a sell rating, nine have given a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $382.24.</p><p><b>Check Out Our Latest Stock Report on UNH</b></p><h2>UnitedHealth Group Trading Down 0.1%</h2><ul><li>Healthcare Stocks Hit Valuation Bottom, 3 Names to Rebound</li></ul><p>NYSE UNH opened at $260.86 on Wednesday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a market capitalization of $236.64 billion, a PE ratio of 10.91, a price-to-earnings-growth ratio of 1.40 and a beta of 0.45. UnitedHealth Group has a one year low of $248.88 and a one year high of $630.73. The company has a 50-day simple moving average of $299.69 and a 200-day simple moving average of $421.43. </p><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $5.16 by ($1.08). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same period last year, the firm posted $6.80 EPS. The business's quarterly revenue was up 12.9% on a year-over-year basis.  On average, equities analysts forecast that  UnitedHealth Group will post 29.54 earnings per share for the current year. </p><h2>Insider Buying and Selling at UnitedHealth Group</h2><ul><li>Insiders Spent Millions on These 3 Stocks Over the Past 2 Months</li></ul><p>In other news, Director Timothy Patrick Flynn purchased 1,533 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director owned 6,033 shares in the company, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their position. The acquisition was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at the SEC website. Also, Director Kristen Gil purchased 3,700 shares of the firm's stock in a transaction on Thursday, May 15th. The stock was acquired at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the transaction, the director owned 3,818 shares in the company, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 109,408 shares of company stock worth $31,607,768 over the last three months. 0.28% of the stock is owned by corporate insiders. </p><h2>Institutional Investors Weigh In On UnitedHealth Group</h2><p>Several institutional investors and hedge funds have recently made changes to their positions in UNH. Brighton Jones LLC increased its stake in  UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after purchasing an additional 28,231 shares in the last quarter.  Revolve Wealth Partners LLC boosted its stake in  UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after purchasing an additional 2,324 shares during the last quarter.  Bank Pictet &amp; Cie Europe AG boosted its position in shares of  UnitedHealth Group by 3.9% during the fourth quarter. Bank Pictet &amp; Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock valued at $133,373,000 after buying an additional 9,872 shares during the last quarter.  Trexquant Investment LP purchased a new stake in  UnitedHealth Group in the 4th quarter valued at $11,141,000.  Finally, Meeder Advisory Services Inc. lifted its position in shares of  UnitedHealth Group by 4.1% during the fourth quarter. Meeder Advisory Services Inc. now owns 17,092 shares of the healthcare conglomerate's stock valued at $8,646,000 after purchasing an additional 668 shares in the last quarter. Institutional investors own  87.86% of the company's stock. </p><h2>UnitedHealth Group Company Profile</h2> (Get Free Report)<p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p><h2>See Also</h2><ul><li>Five stocks we like better than UnitedHealth Group</li><li>How to Buy Gold Stock and Invest in Gold</li><li>Why Coca-Cola Stock Is a Top Pick for Traders Today</li><li>Insider Trading - What You Need to Know</li><li>Why Billions Are Flowing into IBIT, BlackRock's Bitcoin ETF</li><li>How to Invest in the Best Canadian Stocks </li><li>3 Materials Stocks Everyone Is Talking About Right Now</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2><p>Before you consider UnitedHealth Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p><p>While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Piper Sandler has reduced its price target for UnitedHealth Group (NYSE: UNH) from $353.00 to $317.00 while maintaining an "overweight" rating. This new target suggests a potential upside of 21.52% from the current stock price. Other analysts have also adjusted their ratings, with a consensus rating of "Moderate Buy" and a price target of $382.24. UnitedHealth Group's stock opened at $260.86, with a market cap of $236.64 billion and a recent quarterly earnings report showing a miss on EPS estimates.</p>

Piper Sandler Cuts UnitedHealth Group (NYSE:UNH) Price Target to $317.00